Five new customers in Q2 and 13 in the first half of 2026 — including expansion and multi-year agreements with current customers — underscore Enlil's growth trajectory and leadership in MedTech ...

The FDA is already reviewing with AI. Most device makers' evidence wasn't built for that. Enlil's four-layer architecture grounds AI in a unified system of record, so every AI-assisted answer and ...

The all-in-one, cloud-native solution integrates AI-powered intelligence to transform how OEMs and contract manufacturers manage development, ensure compliance, and accelerate time-to-market.

Enlil was founded to solve a critical challenge for medical device innovators: efficiently navigating regulated product development without being hindered by disconnected systems, manual processes, or ...

Eight MedTech innovators, spanning organ perfusion, surgical robotics, Software as a Medical Device, AI-driven imaging, and more, chose Enlil's AI-powered traceability platform in Q1 2026, migrating ...

Enlil, an AI-powered development traceability platform built for medical device organizations, recently announced the strongest revenue quarter in the company’s history. During the second quarter, ...

New alliance between Enlil's AI-powered traceability platform and OVA Solutions' medical device engineering firm targets the "build first, document later" pattern, where even a single undocumented $14 ...

CAMPBELL, Calif., July 30, 2026 /PRNewswire/ -- Enlil, Inc., the AI-powered development traceability platform built for medical device and life sciences organizations, today announced the strongest ...